Sort
51,593 grants matching “hepatitis”
Small Molecule Inhibitors Targeting Adenovirus
$572,326Charles E McKenna · University Of Southern California · R01 · FY2022 · AI
HBV Prevention for Homeless at Risk for HBV/HCV/HIV
$572,305Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2013 · DA
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
$572,286Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2013 · AI
The Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease
$572,237Jeffrey D Browning · Ut Southwestern Medical Center · R01 · FY2011 · DK
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$572,046Carol A Casey · University Of Nebraska Medical Center · R01 · FY2018 · AA
Identifying and modulating therapeutic targets in a model of hepatitis B
$571,983Jody L Baron · University Of California, San Francisco · R01 · FY2020 · AI
Gut microbiota mediated bile acid alterations in hepatic carcinogenesis
$571,982Wei Jia · University Of Hawaii At Manoa · U01 · FY2016 · CA
Molecular Mechanisms of Postnatal Islet alpha-cell Proliferation
$571,913Wenbiao Chen · Vanderbilt University · R01 · FY2019 · DK
Novel Pathways of Cellular Cholesterol Efflux
$571,784Alan Richard Tall · Columbia University Health Sciences · P01 · FY2010 · HL
Acoustic Radiation Force Based Hepatic Elasticity Quantification and Imaging
$571,747Kathryn R Nightingale · Duke University · R01 · FY2014 · EB
SYRINGE EXCHANGE BASED HEPATITIS B VACCINATION OF IDU'S
$571,744Yale University · R01 · FY2003 · DA
METHADONE AND HIV DRUG INTERACTIONS
$571,721Evan D Kharasch · Washington University · R01 · FY2011 · DA
Engineering immunotherapeutic probiotics to mitigate irAE
$571,668Tal Danino · Columbia Univ New York Morningside · U01 · FY2024 · CA
HIV/STD Infection in an Urban High Risk Population
$571,664National Development &Res Institutes · R01 · FY2004 · DA
ANTIVIRAL &ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
$571,650Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · AA
Role of extracellular vesicles in the regulation of immunometabolism in obesity
$571,634Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK
Impact of HIV co-infections and comorbidities on circadian rhythm in the liver
$571,625Eleftherios Michailidis · Emory University · DP1 · FY2024 · DK
Dichloroacetate Kinetics, Metabolism and Toxicology
$571,449University Of Florida · R01 · FY2005 · ES
Prevention of Pediatric NAFLD in Hispanic Children
$571,406Jean A. Welsh · Emory University · R01 · FY2025 · NR
Quantitation of Factors Regulating Glucose Tolerance
$571,344Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2012 · DK
NEUROCOGNITIVE
$571,331Robert Kernachan Heaton · University Of California, San Diego · P01 · FY2009 · DA
Coactivator P300 promotes hepatic steatosis in obesity
$571,325Ling He · Johns Hopkins University · R01 · FY2019 · DK
Genes and Gene Networks Associated with Obesity and Diabetes
$571,323Alan D Attie · University Of Wisconsin-Madison · R01 · FY2014 · DK
Mechanism Of Rotavirus Genome Replication And Packaging
$571,322John Patton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV Infection in Ethnic Minority IDUs: An International Systematic Review
$571,320Don C Des Jarlais · Beth Israel Medical Ctr (New York) · R01 · FY2008 · DA